New $7.7 Million Grant To Propel Search for Drugs for Rare Brain Disorder
Rumbaugh and a team of scientists from the institute have been awarded a five-year grant from the National Institute of Mental Health worth $7.7 million to work toward a treatment. Their goal is to create a pill that restores healthy SYNGAP1 gene production, thereby boosting neuroplasticity, or the ability of the brain to form circuits and connections.
Atsena Therapeutics Receives Rare Pediatric Disease Designation From the U.S. FDA for ATSN-201 Gene Therapy To Treat X-Linked Retinoschisis
UF startup Atsena Therapeutics, a clinical-stage gene therapy company focused on bringing the life-changing power of genetic medicine to reverse or prevent blindness, announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease designation (RPD) for ATSN-201 for the treatment of X-linked retinoschisis (XLRS).
Grant Funds University of Florida Research for Potential Opioid Relief
The USDA National Institute of Food and Agriculture has awarded a $650,000 grant to a UF/IFAS researcher to study a plant that could help mitigate the opioid epidemic, a national health crisis responsible for more than 130 deaths each day.
Tech Tuesday: Local Nonprofit Is Enhancing the Healthcare Experience Through Technology
In this week’s Tech Tuesday, host Bethany Gaffey introduces Dream Team Engineering’s Ashni Zaverchand, president of the nonprofit creating technologies to enhance the healthcare experience for patients and physicians.
UF Graduate Student Start-Up Focuses on Creating Chemicals From Ocean Microbes
In Jules Verne’s 20,000 Leagues Under the Sea, Captain Nemo describes the sea as “everything,” the “vast reservoir of Nature.” A pair of UF Ph.D. students are diving into these vast depths. They are harnessing the power of marine microbes and unlocking their potential for sustainable chemical applications. Jessica Tittl Nielsen (CEO) and Monica Schul (Chief Science Officer) founded a biotechnology company, Cordelia Biosciences, to create sustainable chemicals from ocean microbes.
Oragenics Inc. Announces Concussion Drug, ONP-002, Successfully Clears FDA-Required Cardiotoxicity Testing
UF Innovate | Accelerate graduate Oragenics, Inc., a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, announced its lead candidate for treating concussion successfully completed a study that indicates ONP-002 does not cause cardiotoxicity.
UF-Developed Genetic Score Improves Outcomes by Personalizing Leukemia Therapy
Using patients’ own genetics to tailor their chemotherapy regimens appears to improve outcomes in children with acute myeloid leukemia, a pediatric cancer for which treatment has gone unchanged for 50 years, a new University of Florida Health-led study shows.
University of Florida’s Innovation Academy Showcases Prototypes Created by the Freshmen Class
In this week’s Tech Tuesday, Bethany Gaffey, our host, introduces us to the leader of UF’s Innovation Academy, who recently directed a Catalyst event to showcase prototypes created by the freshman class.
GatorX Advances to Semi-Final Round of XPRIZE Track B Autonomous Wildfire Challenge
Fire Neural Network (FNN) announced that their team, GatorX, is advancing to the semi-final round of the XPRIZE Track B Autonomous Wildfire Challenge. GatorX is a well-rounded partnership between Fire Neural Network, the University of Florida, NVIDIA, SATLANTIS, SwissDrones, Archer Aviation, SWIR Vision Systems, and N5 Sensors.
UF Health Cancer Center Researcher Showcases a New Vaccine That Can Help Fight Diseases
In this week’s Tech Tuesday, UF Innovate host Bethany Gaffey introduces us to the researcher developing a groundbreaking mRNA vaccine with the potential to fight cancer and infectious diseases.
